Revelation Biosciences, Inc.
USD1.04
+0.01 (+0.48%)
CEO
James Rolke
IPO Date
2020-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.04
Prev. Close
$1.04
Day Low
$1.03
Day High
$1.07
52W Low
$0.88
52W High
$12.88
Market Cap
$0.00B
Volume
0.01M
| 13,285 |
| $1.10 |
| 5 Feb 2026 | ROPER JESS | director | F-InKind | Disposed | 1,591 | $1.85 |
| 5 Feb 2026 | Chawla Lakhmir S | director | F-InKind | Disposed | 2,261 | $1.85 |
| 5 Feb 2026 | CARVER JENNIFER | director | F-InKind | Disposed | 1,661 | $1.87 |
| 5 Feb 2026 | Rolke James | director, officer: Chief Executive Officer | F-InKind | Disposed | 8,521 | $1.86 |
| 5 Feb 2026 | Zygmont Chester Stanley III | Chief Financial Officer | F-InKind | Disposed | 13,100 | $1.65 |
| 12 Jan 2026 | Rolke James | director, officer: Chief Executive Officer | A-Award | Acquired | 532,829 | $0.90 |
| 12 Jan 2026 | Zygmont Chester Stanley III | Chief Financial Officer | A-Award | Acquired | 78,145 | $0.90 |
| 12 Jan 2026 | CARVER JENNIFER | director | A-Award | Acquired | 41,981 | $0.90 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $15,001 - $50,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $1,001 - $15,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $15,001 - $50,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $1,001 - $15,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $15,001 - $50,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $1,001 - $15,000 |
| 12 Aug 2019 | Pat Toomey | Pat Toomey | Sale (Partial) | $1,001 - $15,000 |